Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Clusterin inhibits apoptosis by interacting with activated Bax

Abstract

Clusterin is an enigmatic glycoprotein that is overexpressed in several human cancers such as prostate and breast cancers, and squamous cell carcinoma1,2. Because the suppression of clusterin expression renders human cancer cells sensitive to chemotherapeutic drug-mediated apoptosis, it is currently an antisense target in clinical trials for prostate cancer. However, the molecular mechanisms by which clusterin inhibits apoptosis in human cancer cells are unknown. Here we report that intracellular clusterin inhibits apoptosis by interfering with Bax activation in mitochondria. Intriguingly, in contrast to other inhibitors of Bax, clusterin specifically interacts with conformation-altered Bax in response to chemotherapeutic drugs. This interaction impedes Bax oligomerization, which leads to the release of cytochrome c from mitochondria and caspase activation. Moreover, we also find that clusterin inhibits oncogenic c-Myc-mediated apoptosis by interacting with conformation-altered Bax. Clusterin promotes c-Myc-mediated transformation in vitro and tumour progression in vivo. Taken together, our results suggest that the elevated level of clusterin in human cancers may promote oncogenic transformation and tumour progression by interfering with Bax pro-apoptotic activities.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Clusterin inhibits apoptosis in HT1080 cells.
Figure 2: Clusterin interacts with conformation-altered Bax and inhibits its oligomerization in HT1080 cells.
Figure 3: Clusterin inhibits c-Myc-mediated apoptosis by interacting with conformation-altered Bax.
Figure 4: Clusterin cooperates with c-Myc in oncogenic transformation in vitro and in tumour formation and progression in vivo.
Figure 5: The elevated endogenous clusterin interacted with conformation-altered Bax and inhibited apoptosis in prostate cancer cells.

Similar content being viewed by others

Accession codes

Accessions

BINDPlus

GenBank/EMBL/DDBJ

References

  1. Gleave, M. & Jansen B. Clusterin and IGFBPs as antisense targets in prostate cancer. Ann. NY Acad. Sci. 1002, 95–104 (2003).

    Article  CAS  PubMed  Google Scholar 

  2. Trougakos, I. P. & Gonos, E. S. Clusterin/Apolipoprotein in human aging and cancer. Int. J. Biochem. Cell Biol. 34, 1430–1448 (2002).

    Article  CAS  PubMed  Google Scholar 

  3. Miyake, H., Hara, I., Kamidono, S., Gleave, M. E. & Eto, H. Resistance to cytotoxic chemotherapy-induced apoptosis in human prostate cancer cells is associated with intracellular clusterin expression. Oncol. Rep. 10, 469–473 (2003).

    CAS  PubMed  Google Scholar 

  4. Viard, I. et al. Clusterin gene expression mediates resistance to apoptotic cell death induced by heat shock and oxidative stress. J. Inv. Derm. 112, 290–296 (1999).

    Article  CAS  Google Scholar 

  5. Trougakos, I. P., So, A., Jansen, B., Gleave, M. E. & Gonos, E. S. Silencing expression of the clusterin/apolipoprotein J gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress. Can. Res. 64, 1834–1842 (2004).

    Article  CAS  Google Scholar 

  6. Wang, S. et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer Can. Cell 4, 209–221 (2003).

    Article  CAS  Google Scholar 

  7. Chen, X., Halberg, R. B., Ehrhardt, W. M., Torrealba, J. & Dove, W. F. Clusterin as a biomarker in murine and human intestinal neoplasia. Proc. Natl Acad. Sci. USA 100, 9530–9535 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Reed, J. C. & Green, D. R. Remodeling for demolition: Changes in mitochrondrial ultrastructure during apoptosis. Mol. Cell 9, 1–3 (2002).

    Article  CAS  PubMed  Google Scholar 

  9. Wang, X. The expanding role of mitochondria in apoptosis. Genes Dev. 15, 2922–2933 (2001).

    CAS  PubMed  Google Scholar 

  10. Zong, W., Lindsten, T., Ross, A. J., MacGregor, G. R. & Thompson, C. B. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 15, 1481–1486 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Kuwana, T. et al. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111, 331–342 (2002).

    Article  CAS  PubMed  Google Scholar 

  12. Perez, D. & White, E. TNF-α signals apoptosis through a Bid-dependent conformational change in Bax that is inhibited by E1B 19K. Mol. Cell 6, 53–63 (2000).

    Article  CAS  PubMed  Google Scholar 

  13. Cheng, E. H. et al. BCL-2, BCL-XL sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell. 8, 705–711 (2001).

    Article  CAS  PubMed  Google Scholar 

  14. Li, H., Zhu, H., Xu, C. J. & Yuan, J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491–501 (1998).

    Article  CAS  PubMed  Google Scholar 

  15. Arnoult, D. et al. Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization. EMBO J. 22, 4385–4399 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Wei, M. et al. Proapoptotic Bax and Bak: A requisite gateway to mitochondrial dysfunction and death. Science 292, 727–730 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Hsu, Y. T. & Youle, R. J. Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. J. Biol. Chem. 273, 10777–10783 (1998).

    Article  CAS  PubMed  Google Scholar 

  18. Vaux, D. L., Cory, S. & Adams, J. M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335, 440–442 (1988).

    Article  CAS  PubMed  Google Scholar 

  19. Bissonnette, R. P., Echeverri, F., Mahboubi, A. & Green, D. R. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359, 552–554 (1992).

    Article  CAS  PubMed  Google Scholar 

  20. Juin, P. et al. c-Myc functionally cooperates with Bax to induce apoptosis. Mol. Cell. Biol. 22, 6158–6169 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Soucie, E. L. et al. Myc potentiates apoptosis by stimulating Bax activity at the mitochondria. Mol. Cell. Biol. 21, 4725–4736 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Eischen, C. M., Roussel, M. F., Korsmeyer, S. J. & Cleveland, J. L. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis. Mol. Cell. Biol. 21, 7653–7662 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. You, Z. et al. Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J. Cell. Biol. 157, 429–440 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Guo, B. et al. Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 423, 456–461 (2003).

    Article  CAS  PubMed  Google Scholar 

  25. Sawada, M. et al. Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nature Cell Biol. 5, 320–329 (2003).

    Article  CAS  PubMed  Google Scholar 

  26. O'Sullivan, J. Whyte, L., Drake, J. & Tenniswood, M. Alterations in the post-translational modification and intracellular trafficking of clusterin in MCF-7 cells during apoptosis. Cell Death Differ. 10, 914–927 (2003).

    Article  CAS  PubMed  Google Scholar 

  27. Leskov, K. S., Klokov, D. Y., Li, J., Kinsella, T. J. & Boothman, D. A. Synthesis and functional analyses of nuclear clusterin, a cell death protein. J. Biol. Chem. 278, 11590–11600 (2003).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Z. You for technical help, A. S. Baldwin for critically reading the manuscript and E. White for inspiring discussion. This study was supported by National Institutes of Health and the US Army Research Office (DAAD19-03-1-0168).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cun-Yu Wang.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Information

Supplementary figures S1, S2, S3, S4 and S5 (PDF 682 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, H., Kim, J., Edwards, C. et al. Clusterin inhibits apoptosis by interacting with activated Bax. Nat Cell Biol 7, 909–915 (2005). https://doi.org/10.1038/ncb1291

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncb1291

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing